October 15 - 18, 2019 | Sheraton Boston, MA

USP <1079> and the Evolution of GDP

USP <1079> and the Evolution of GDP

Review the increased globalization of the pharmaceutical industry and its impact on the handling, storage, and distribution of products.

  • Take a life cycle management approach to quality, ranging from material procurement to manufacturing to delivery of a final product to the patient
  • Ensure each activity in the distribution of a product is carried out according to the principle of Good Distribution Practices (GDP)
  • Identify common risks in the storage and transportation of finished drug products and recommended mitigation strategies for these risks

Presentation by Chris J Anderson, Director, Quality Systems, Cardinal Health, USP Packaging and Distribution Expert Committee Member USP Sub-Committee Co-Chair, U.S. Pharmacopeia.

Please note: That all fields marked with an asterisk (*) are required.